Combination of compounds for treating or preventing skin diseases

A compound and dermatology technology, applied in skin diseases, drug combinations, active ingredients of anhydride/acid/halide, etc., can solve problems such as irritation or intolerance

Inactive Publication Date: 2013-06-05
GALDERMA RES & DEV SNC
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] These treatments have unpleasant side effects for patients, such as irritation or intolerance
Additionally, no existing treatment is effective in treating and / or preventing all symptoms associated with rosacea

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination of compounds for treating or preventing skin diseases
  • Combination of compounds for treating or preventing skin diseases
  • Combination of compounds for treating or preventing skin diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0112] Embodiment 1: Brimonidine 0.20% / Azelaic acid 15% solution

[0113] Element

Embodiment 2

[0114] Embodiment 2: Brimonidine 0.15% / Azelaic Acid 10% Solution

[0115] Element

Embodiment 3

[0116] Embodiment 3: Brimonidine 0.18% / Azelaic Acid 10% Gel

[0117] Element

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a combination of compounds for treating skin diseases and particularly rosacea and ocular rosacea. It is the combination of a compound selected from azelaic acid and salts thereof with a compound of the alpha-1 or alpha-2 adrenergic receptor agonist family. The invention also relates to a product in the form of a kit containing: (a) a first composition comprising a compound selected from azelaic acid and salts thereof, and (b) a second composition different from the first one and comprising a compound of the alpha-1 or alpha-2 adrenergic receptor agonist family, as a combination product for application thereof as a medicament for treating and/or preventing skin diseases and in particular rosacea and ocular rosacea, wherein said first and second compositions can be applied simultaneously, separately or with a time delay.

Description

technical field [0001] The present invention relates to combinations of compounds useful in the treatment of human skin diseases, especially rosacea and ocular rosacea. Background technique [0002] Rosacea is a common chronic, progressive inflammatory dermatitis associated with vasodilation. It mainly affects the middle part of the face and is characterized by redness or hot flashes of the face, facial erythema, papules, pustules, telangiectasias and sometimes ocular lesions, called ocular rosacea. In severe cases, especially in men, the soft tissues of the nose swell and produce a bulbous swelling called hypertrophic rosacea. [0003] Rosacea usually occurs between the ages of 25 and 70, and it is more common in people with fair skin. Although the disease is generally more severe in men, it more particularly affects women. Rosacea is chronic and lasts for years in cycles of exacerbations and remissions. [0004] The pathogenesis of rosacea is poorly understood. Many f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K31/00A61K31/20A61K31/498A61P17/00A61P27/02
CPCA61K9/0048A61K31/00A61K31/20A61K31/194A61K31/498A61K9/0014A61K45/06A61P17/00A61P27/02A61K2300/00
Inventor J-P·沙皮伊E·艾特
Owner GALDERMA RES & DEV SNC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products